Atlas Trials

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Clinical trial NCT00368069 · COMPLETED

Trial details

NCT number
NCT00368069
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsy
Start date
2006-08-01
Primary completion
2007-05-01
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.